Gene · 64006
Papers4,423
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 4,423
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Attenuation of SARS-CoV-2 replication and associated inflammation by concomitant targeting of viral and host cap 2'-O-ribose methyltransferases. | EMBO J | 2022 | 35833542 | PubTator, text mining | PubMed |
| Development of a prediction score (ThyroCOVID) for identifying abnormal thyroid function in COVID-19 patients. | J Endocrinol Invest | 2022 | 35831586 | PubTator, text mining | PubMed |
| Simulation of group testing scenarios can boost COVID-19 screening power. | Sci Rep | 2022 | 35831373 | PubTator, text mining | PubMed |
| Generation of soluble, cleaved, well-ordered, native-like dimers of dengue virus 4 envelope protein ectodomain (sE) suitable for vaccine immunogen design. | Int J Biol Macromol | 2022 | 35817240 | PubTator, text mining | PubMed |
| Good and bad get together: Inactivation of SARS-CoV-2 in particulate matter pollution from different fuels. | Sci Total Environ | 2022 | 35817121 | PubTator, text mining | PubMed |
| Recent trends and advancements in electrochemiluminescence biosensors for human virus detection. | Trends Analyt Chem | 2022 | 35815064 | PubTator, text mining | PubMed |
| Mild and Asymptomatic Coronavirus Disease in Children, Adolescents, and Household Contacts and Prolonged Viral Excretion. | Int J Microbiol | 2022 | 35813120 | PubTator, text mining | PubMed |
| Investigation of Antibody Levels During Three Doses of Sinopharm/BBIBP Vaccine Inoculation. | Front Immunol | 2022 | 35812449 | PubTator, text mining | PubMed |
| The beneficial role of Hepcidin peptide inhibitor in improved the symptoms of COVID-19 in diabetics: anti-inflammatory and potential therapeutic effects. | J Diabetes Metab Disord | 2022 | 35812243 | PubTator, text mining | PubMed |
| Andrographolide induces anti-SARS-CoV-2 response through host-directed mechanism: an in silico study. | Future Virol | 2022 | 35812188 | PubTator, text mining | PubMed |
| Molecular docking and machine learning affinity prediction of compounds identified upon softwood bark extraction to the main protease of the SARS-CoV-2 virus. | Biophys Chem | 2022 | 35810518 | PubTator, text mining | PubMed |
| In-silico screening and in-vitro assay show the antiviral effect of Indomethacin against SARS-CoV-2. | Comput Biol Med | 2022 | 35809412 | PubTator, text mining | PubMed |
| Vitamin D Endocrine System and COVID-19: Treatment with Calcifediol. | Nutrients | 2022 | 35807895 | PubTator, text mining | PubMed |
Variability in Susceptibility to Type I Interferon Response and Subgenomic RNA Accumulation Between Clinical Isolates of Dengue and Zika Virus From Oaxaca Mexico Correlate With Replication Efficiency in Human Cells and Disease Severity. | Front Cell Infect Microbiol | 2022 | 35800385 | PubTator, text mining | PubMed |
| Chalcone-amide, a privileged backbone for the design and development of selective SARS-CoV/SARS-CoV-2 papain-like protease inhibitors. | Eur J Med Chem | 2022 | 35797899 | PubTator, text mining | PubMed |
| A Review of the Potential Effects of Melatonin in Compromised Mitochondrial Redox Activities in Elderly Patients With COVID-19. | Front Nutr | 2022 | 35795579 | PubTator, text mining | PubMed |
| An outlook on potential protein targets of COVID-19 as a druggable site. | Mol Biol Rep | 2022 | 35790657 | PubTator, text mining | PubMed |
| Drug repurposing against main protease and RNA-dependent RNA polymerase of SARS-CoV-2 using molecular docking, MM-GBSA calculations and molecular dynamics. | Struct Chem | 2022 | 35789829 | PubTator, text mining | PubMed |
| SARS-CoV-2 infection in multiple sclerosis patients: interaction with treatments, adjuvant therapies, and vaccines against COVID-19. | J Neurol | 2022 | 35788744 | PubTator, text mining | PubMed |
| MiRNA-SARS-CoV-2 dialogue and prospective anti-COVID-19 therapies. | Life Sci | 2022 | 35787998 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64006/papers?page=48